These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 17215249

  • 1. Ganglioside GM2-tetraspanin CD82 complex inhibits met and its cross-talk with integrins, providing a basis for control of cell motility through glycosynapse.
    Todeschini AR, Dos Santos JN, Handa K, Hakomori SI.
    J Biol Chem; 2007 Mar 16; 282(11):8123-33. PubMed ID: 17215249
    [Abstract] [Full Text] [Related]

  • 2. A specific microdomain ("glycosynapse 3") controls phenotypic conversion and reversion of bladder cancer cells through GM3-mediated interaction of alpha3beta1 integrin with CD9.
    Mitsuzuka K, Handa K, Satoh M, Arai Y, Hakomori S.
    J Biol Chem; 2005 Oct 21; 280(42):35545-53. PubMed ID: 16103120
    [Abstract] [Full Text] [Related]

  • 3. Ganglioside GM2/GM3 complex affixed on silica nanospheres strongly inhibits cell motility through CD82/cMet-mediated pathway.
    Todeschini AR, Dos Santos JN, Handa K, Hakomori SI.
    Proc Natl Acad Sci U S A; 2008 Feb 12; 105(6):1925-30. PubMed ID: 18272501
    [Abstract] [Full Text] [Related]

  • 4. Synergistic inhibition of cell migration by tetraspanin CD82 and gangliosides occurs via the EGFR or cMet-activated Pl3K/Akt signalling pathway.
    Li Y, Huang X, Zhang J, Li Y, Ma K.
    Int J Biochem Cell Biol; 2013 Nov 12; 45(11):2349-58. PubMed ID: 23968914
    [Abstract] [Full Text] [Related]

  • 5. Control of cell motility by interaction of gangliosides, tetraspanins, and epidermal growth factor receptor in A431 versus KB epidermoid tumor cells.
    Park SY, Yoon SJ, Freire-de-Lima L, Kim JH, Hakomori SI.
    Carbohydr Res; 2009 Aug 17; 344(12):1479-86. PubMed ID: 19559406
    [Abstract] [Full Text] [Related]

  • 6. GM2/GM3 controls the organizational status of CD82/Met microdomains: further studies in GM2/GM3 complexation.
    Santos RCM, Lucena DMS, Loponte HFBR, Alisson-Silva F, Dias WB, Lins RD, Todeschini AR.
    Glycoconj J; 2022 Oct 17; 39(5):653-661. PubMed ID: 35536494
    [Abstract] [Full Text] [Related]

  • 7. Gangliosides and CD82 inhibit the motility of colon cancer by downregulating the phosphorylation of EGFR at different tyrosine sites and signaling pathways.
    Huang X, Li Y, He X, Chen Y, Wei W, Yang X, Ma K.
    Mol Med Rep; 2020 Nov 17; 22(5):3994-4002. PubMed ID: 33000220
    [Abstract] [Full Text] [Related]

  • 8. Functional role of glycosphingolipids and gangliosides in control of cell adhesion, motility, and growth, through glycosynaptic microdomains.
    Regina Todeschini A, Hakomori SI.
    Biochim Biophys Acta; 2008 Mar 17; 1780(3):421-33. PubMed ID: 17991443
    [Abstract] [Full Text] [Related]

  • 9. Tetraspanin KAI1/CD82 suppresses invasion by inhibiting integrin-dependent crosstalk with c-Met receptor and Src kinases.
    Sridhar SC, Miranti CK.
    Oncogene; 2006 Apr 13; 25(16):2367-78. PubMed ID: 16331263
    [Abstract] [Full Text] [Related]

  • 10. Tetraspanin CD82 attenuates cellular morphogenesis through down-regulating integrin alpha6-mediated cell adhesion.
    He B, Liu L, Cook GA, Grgurevich S, Jennings LK, Zhang XA.
    J Biol Chem; 2005 Feb 04; 280(5):3346-54. PubMed ID: 15557282
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Regulation of c-Met signaling by the tetraspanin KAI-1/CD82 affects cancer cell migration.
    Takahashi M, Sugiura T, Abe M, Ishii K, Shirasuna K.
    Int J Cancer; 2007 Nov 01; 121(9):1919-1929. PubMed ID: 17621632
    [Abstract] [Full Text] [Related]

  • 14. Effect of ganglioside and tetraspanins in microdomains on interaction of integrins with fibroblast growth factor receptor.
    Toledo MS, Suzuki E, Handa K, Hakomori S.
    J Biol Chem; 2005 Apr 22; 280(16):16227-34. PubMed ID: 15710618
    [Abstract] [Full Text] [Related]

  • 15. Glycosylation effect on membrane domain (GEM) involved in cell adhesion and motility: a preliminary note on functional alpha3, alpha5-CD82 glycosylation complex in ldlD 14 cells.
    Ono M, Handa K, Withers DA, Hakomori S.
    Biochem Biophys Res Commun; 2000 Dec 29; 279(3):744-50. PubMed ID: 11162423
    [Abstract] [Full Text] [Related]

  • 16. Ganglioside GM2 mediates migration of tumor cells by interacting with integrin and modulating the downstream signaling pathway.
    Kundu M, Mahata B, Banerjee A, Chakraborty S, Debnath S, Ray SS, Ghosh Z, Biswas K.
    Biochim Biophys Acta; 2016 Jul 29; 1863(7 Pt A):1472-89. PubMed ID: 27066976
    [Abstract] [Full Text] [Related]

  • 17. Ganglioside GD1a inhibits HGF-induced motility and scattering of cancer cells through suppression of tyrosine phosphorylation of c-Met.
    Hyuga S, Kawasaki N, Hyuga M, Ohta M, Shibayama R, Kawanishi T, Yamagata S, Yamagata T, Hayakawa T.
    Int J Cancer; 2001 Nov 01; 94(3):328-34. PubMed ID: 11745410
    [Abstract] [Full Text] [Related]

  • 18. Globoside promotes activation of ERK by interaction with the epidermal growth factor receptor.
    Park SY, Kwak CY, Shayman JA, Kim JH.
    Biochim Biophys Acta; 2012 Jul 01; 1820(7):1141-8. PubMed ID: 22542783
    [Abstract] [Full Text] [Related]

  • 19. Gangliosides play an important role in the organization of CD82-enriched microdomains.
    Odintsova E, Butters TD, Monti E, Sprong H, van Meer G, Berditchevski F.
    Biochem J; 2006 Dec 01; 400(2):315-25. PubMed ID: 16859490
    [Abstract] [Full Text] [Related]

  • 20. A glycosphingolipid/caveolin-1 signaling complex inhibits motility of human ovarian carcinoma cells.
    Prinetti A, Cao T, Illuzzi G, Prioni S, Aureli M, Gagliano N, Tredici G, Rodriguez-Menendez V, Chigorno V, Sonnino S.
    J Biol Chem; 2011 Nov 25; 286(47):40900-10. PubMed ID: 21949119
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.